Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Stem Cell Research

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 330 articles:
HTML format
Text format



Single Articles


    June 2019
  1. GOMEZ-ARTEAGA A, Mark TM, Guarneri D, Christos PJ, et al
    High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.
    Bone Marrow Transplant. 2019 Jun 12. pii: 10.1038/s41409-019-0587.
    PubMed     Text format     Abstract available


  2. MILLER KC, Gertz MA, Buadi FK, Hayman SR, et al
    The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma.
    Bone Marrow Transplant. 2019 Jun 12. pii: 10.1038/s41409-019-0590.
    PubMed     Text format     Abstract available


  3. NAKAGAKI M, Button E, Keating A, Marsh J, et al
    Hyperhydration is not necessary for high-dose melphalan in stem cell transplantation.
    Bone Marrow Transplant. 2019 Jun 11. pii: 10.1038/s41409-019-0586.
    PubMed     Text format    


  4. ZHAO Y, Shi J, Li X, Wang J, et al
    Salvage therapy with dose-escalating ruxolitinib as a bridge to allogeneic stem cell transplantation for refractory hemophagocytic lymphohistiocytosis.
    Bone Marrow Transplant. 2019 Jun 4. pii: 10.1038/s41409-019-0577.
    PubMed     Text format    


  5. RUUTU T, van der Werf S, van Biezen A, Backman JT, et al
    Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2019 Jun 3. pii: 10.1038/s41409-019-0579.
    PubMed     Text format     Abstract available


    May 2019
  6. YANO S, Yokoyama H, Yanada M, Mori J, et al
    Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0571.
    PubMed     Text format     Abstract available


  7. DIETRICH S, Dreger P, Hermine O, Kyriakou C, et al
    Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0583.
    PubMed     Text format     Abstract available


  8. TUCCI F, Frittoli M, Barzaghi F, Calbi V, et al
    Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0573.
    PubMed     Text format     Abstract available


  9. RUGGERI A, Labopin M, Savani B, Paviglianiti A, et al
    Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0582.
    PubMed     Text format     Abstract available


  10. VIJAYVARGIYA P, Gonsalves W, Burton D, Hogan WJ, et al
    Increased fecal primary bile acids in multiple myeloma with engraftment syndrome diarrhea after stem cell transplant.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0581.
    PubMed     Text format     Abstract available


  11. HEUMULLER A, Wehrle J, Stosch J, Niemoller C, et al
    Clonal hematopoiesis of indeterminate potential in older patients having received an allogeneic stem cell transplantation from young donors.
    Bone Marrow Transplant. 2019 May 30. pii: 10.1038/s41409-019-0575.
    PubMed     Text format    


  12. KAITO S, Sekiya N, Najima Y, Suzuki T, et al
    Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 May 29. pii: 10.1038/s41409-019-0541.
    PubMed     Text format    


  13. BIRAN N, Rowley SD, Vesole DH, Zhang S, et al
    A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma.
    Bone Marrow Transplant. 2019 May 17. pii: 10.1038/s41409-019-0534.
    PubMed     Text format     Abstract available


  14. LANGEBRAKE C, Admiraal R, van Maarseveen E, Bonnin A, et al
    Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 May 17. pii: 10.1038/s41409-019-0538.
    PubMed     Text format    


  15. IIDA M, Kodera Y, Dodds A, Ho AYL, et al
    Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005-2015.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0554.
    PubMed     Text format     Abstract available


  16. BABOR F, Peters C, Manser AR, Glogova E, et al
    Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0543.
    PubMed     Text format     Abstract available


  17. AL HAMED R, Bazarbachi AH, Mohty M
    Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0548.
    PubMed     Text format     Abstract available


  18. SENN-MALASHONAK A, Wallek S, Schmidt K, Rosenhagen A, et al
    Psychophysical effects of an exercise therapy during pediatric stem cell transplantation: a randomized controlled trial.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0535.
    PubMed     Text format     Abstract available


  19. PUNATAR S, Mohite A, Gokarn A, Nayak L, et al
    Leflunomide for chronic musculoskeletal graft versus host disease following allogeneic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0545.
    PubMed     Text format    


  20. GUILLAUME T, Malard F, Magro L, Labopin M, et al
    Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0536.
    PubMed     Text format     Abstract available


  21. AXT L, Naumann A, Toennies J, Haen SP, et al
    Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0544.
    PubMed     Text format     Abstract available


  22. ESTEVES I, Santos FPS, Fernandes JF, Seber A, et al
    Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0521.
    PubMed     Text format     Abstract available


  23. KATOH D, Ochi Y, Hiramoto N, Morita M, et al
    Parvovirus B19 infection in adult patients after allogeneic stem cell transplantation: our experience of five cases and literature review.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0533.
    PubMed     Text format    


  24. NISHIWAKI S, Miyamura K, Kanda Y, Takanashi M, et al
    A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0542.
    PubMed     Text format    


  25. CAMPAGNA A, Gianfelici V, Antolino G, Pelliccia S, et al
    Central nervous system immune reconstitution inflammatory syndrome after autologous stem cell transplantation.
    Bone Marrow Transplant. 2019 May 8. pii: 10.1038/s41409-019-0532.
    PubMed     Text format    


    April 2019
  26. OEVERMANN L, Zimmermann C, Voigt S, Kunkele A, et al
    Transmission of chromosomally integrated human herpes virus-6A via haploidentical stem cell transplantation poses a risk for virus reactivation and associated complications.
    Bone Marrow Transplant. 2019 Apr 15. pii: 10.1038/s41409-019-0530.
    PubMed     Text format    


  27. YAMASAKI S, Aoki J, Mori J, Mizuno S, et al
    Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease.
    Bone Marrow Transplant. 2019 Apr 10. pii: 10.1038/s41409-019-0527.
    PubMed     Text format    


  28. WIENER L, Hoag JA, Pelletier W, Shah NN, et al
    Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donors.
    Bone Marrow Transplant. 2019 Apr 10. pii: 10.1038/s41409-019-0515.
    PubMed     Text format     Abstract available


  29. SIDIQI MH, Nadiminti K, Al Saleh AS, Meleveedu K, et al
    Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function.
    Bone Marrow Transplant. 2019 Apr 8. pii: 10.1038/s41409-019-0524.
    PubMed     Text format     Abstract available


  30. LUBKING A, Dreimane A, Sandin F, Isaksson C, et al
    Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry.
    Bone Marrow Transplant. 2019 Apr 8. pii: 10.1038/s41409-019-0513.
    PubMed     Text format     Abstract available


  31. DUARTE RF, Labopin M, Bader P, Basak GW, et al
    Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019.
    Bone Marrow Transplant. 2019 Apr 5. pii: 10.1038/s41409-019-0516.
    PubMed     Text format     Abstract available


  32. SOLH MM, Dickhaus E, Solomon SR, Morris LE, et al
    Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes.
    Bone Marrow Transplant. 2019 Apr 5. pii: 10.1038/s41409-019-0522.
    PubMed     Text format     Abstract available


  33. BUHLER S, Baldomero H, Ferrari-Lacraz S, Nunes JM, et al
    High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Apr 5. pii: 10.1038/s41409-019-0520.
    PubMed     Text format     Abstract available


    March 2019
  34. DANIEL-MORENO A, Lamsfus-Calle A, Raju J, Antony JS, et al
    CRISPR/Cas9-modified hematopoietic stem cells-present and future perspectives for stem cell transplantation.
    Bone Marrow Transplant. 2019 Mar 22. pii: 10.1038/s41409-019-0510.
    PubMed     Text format     Abstract available


  35. XU ZL, Xu LP, Zhang YY, Cheng YF, et al
    Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Mar 21. pii: 10.1038/s41409-019-0509.
    PubMed     Text format     Abstract available


  36. KISHIMOTO K, Hasegawa D, Kawasaki K, Tamura A, et al
    Early posttransplant plasma ADAMTS13 activity reduction in stem cell transplantation: a prospective study of 46 pediatric patients.
    Bone Marrow Transplant. 2019 Mar 19. pii: 10.1038/s41409-019-0506.
    PubMed     Text format    


  37. GRANATA A, Furst S, Bramanti S, Legrand F, et al
    Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients.
    Bone Marrow Transplant. 2019 Mar 19. pii: 10.1038/s41409-019-0500.
    PubMed     Text format     Abstract available


  38. KARLAS T, Weisse T, Petroff D, Beer S, et al
    Author Correction: Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement.
    Bone Marrow Transplant. 2019 Mar 19. pii: 10.1038/s41409-019-0512.
    PubMed     Text format     Abstract available


  39. KIMURA F, Kanda J, Ishiyama K, Yabe T, et al
    ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2019 Mar 13. pii: 10.1038/s41409-019-0496.
    PubMed     Text format     Abstract available


  40. LUO Y, Jin M, Tan Y, Zhao Y, et al
    Antithymocyte globulin improves GVHD-free and relapse-free survival in unrelated hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Mar 13. pii: 10.1038/s41409-019-0502.
    PubMed     Text format     Abstract available


  41. PHILLIPS EH, Lannon MM, Lopes A, Chadwick H, et al
    Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
    Bone Marrow Transplant. 2019 Mar 12. pii: 10.1038/s41409-019-0504.
    PubMed     Text format     Abstract available


  42. HOLDERRIED TAW, Fraccaroli A, Schumacher M, Heine A, et al
    The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin's Lymphoma.
    Bone Marrow Transplant. 2019 Mar 4. pii: 10.1038/s41409-019-0498.
    PubMed     Text format     Abstract available


  43. LA ROCCA U, Perrone MP, Piciocchi A, Cinti P, et al
    Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol.
    Bone Marrow Transplant. 2019 Mar 4. pii: 10.1038/s41409-019-0497.
    PubMed     Text format    


    February 2019
  44. KARLAS T, Weisse T, Petroff D, Beer S, et al
    Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement.
    Bone Marrow Transplant. 2019 Feb 26. pii: 10.1038/s41409-019-0464.
    PubMed     Text format     Abstract available


  45. BAUMGARTNER A, Moesch M, Zumsteg M, Struja T, et al
    Predictors of impaired bone health in long-term survivors after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Feb 26. pii: 10.1038/s41409-019-0484.
    PubMed     Text format     Abstract available


  46. KATO K, Mori T, Kim SW, Sawa M, et al
    Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantati
    Bone Marrow Transplant. 2019 Feb 26. pii: 10.1038/s41409-019-0491.
    PubMed     Text format    


  47. HUBEL K, Re A, Boumendil A, Finel H, et al
    Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2019 Feb 25. pii: 10.1038/s41409-019-0480.
    PubMed     Text format     Abstract available


  48. KOO J, Silverman S, Nuechterlein B, Keating AK, et al
    Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors.
    Bone Marrow Transplant. 2019 Feb 19. pii: 10.1038/s41409-019-0479.
    PubMed     Text format     Abstract available


  49. MIZUNO S, Kawamura K, Hanamura I, Sunami K, et al
    Efficacy and safety of autologous stem cell transplantation in patients aged >/= 65 years with multiple myeloma in the era of novel agents.
    Bone Marrow Transplant. 2019 Feb 19. pii: 10.1038/s41409-019-0478.
    PubMed     Text format     Abstract available


  50. FAYARD A, Daguenet E, Blaise D, Chevallier P, et al
    Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem
    Bone Marrow Transplant. 2019 Feb 15. pii: 10.1038/s41409-019-0475.
    PubMed     Text format     Abstract available


  51. GABALLA A, Stikvoort A, Onfelt B, Mattsson J, et al
    T-cell frequencies of CD8(+) gammadelta and CD27(+) gammadelta cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2019 Feb 5. pii: 10.1038/s41409-019-0462.
    PubMed     Text format     Abstract available


  52. ITONAGA H, Ishiyama K, Aoki K, Aoki J, et al
    Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0469.
    PubMed     Text format     Abstract available


  53. JOHANSSON JE, Bratel J, Hardling M, Heikki L, et al
    Cryotherapy as prophylaxis against oral mucositis after high-dose melphalan and autologous stem cell transplantation for myeloma: a randomised, open-label, phase 3, non-inferiority trial.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0468.
    PubMed     Text format     Abstract available


  54. SENGELOV H, Petersen PM, Fog L, Schmidt M, et al
    Less mucositis toxicity after 6 versus 3 fractions of high-dose total body irradiation before allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0470.
    PubMed     Text format    


  55. OKAMOTO Y, Kudo K, Tabuchi K, Tomizawa D, et al
    Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0461.
    PubMed     Text format     Abstract available


  56. FARNAULT L, Venton G, Pourroy B, Jourde-Chiche N, et al
    Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0467.
    PubMed     Text format    


  57. BATTIPAGLIA G, Boumendil A, Labopin M, Ciceri F, et al
    Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0459.
    PubMed     Text format     Abstract available


  58. SINGER S, Sharma N, Dean R, Zhao Q, et al
    BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin's lymphomas.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0463.
    PubMed     Text format     Abstract available


  59. ZHANG YY, Mo XD, Zhang XH, Xu LP, et al
    FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients.
    Bone Marrow Transplant. 2019 Feb 1. pii: 10.1038/s41409-019-0456.
    PubMed     Text format     Abstract available


    January 2019
  60. JESSOP H, Farge D, Saccardi R, Alexander T, et al
    General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT
    Bone Marrow Transplant. 2019 Jan 31. pii: 10.1038/s41409-019-0430.
    PubMed     Text format     Abstract available


  61. BENOIT SW, Dixon BP, Goldstein SL, Bennett MR, et al
    A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 30. pii: 10.1038/s41409-018-0428.
    PubMed     Text format     Abstract available


  62. POIREL HA, Vanspauwen M, Macq G, De Geyndt A, et al
    Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.
    Bone Marrow Transplant. 2019 Jan 29. pii: 10.1038/s41409-019-0458.
    PubMed     Text format     Abstract available


  63. ABIDI MZ, Hari P, Chen M, Kim S, et al
    Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study.
    Bone Marrow Transplant. 2019 Jan 29. pii: 10.1038/s41409-019-0457.
    PubMed     Text format     Abstract available


  64. WEN Q, Kong Y, Zhao HY, Zhang YY, et al
    G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 25. pii: 10.1038/s41409-019-0449.
    PubMed     Text format     Abstract available


  65. MARIOTTI J, Granata A, Bramanti S, Devillier R, et al
    The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2019 Jan 24. pii: 10.1038/s41409-019-0453.
    PubMed     Text format     Abstract available


  66. FUJIWARA SI, Kanda J, Tatara R, Ogawa H, et al
    Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 22. pii: 10.1038/s41409-019-0434.
    PubMed     Text format     Abstract available


  67. GUTIERREZ-GARCIA G, Cibeira MT, Rovira M, Fernandez de Larrea C, et al
    Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0447.
    PubMed     Text format     Abstract available


  68. PHULL P, Sanchorawala V, Brauneis D, Sloan JM, et al
    High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0440.
    PubMed     Text format     Abstract available


  69. FU H, Zhang X, Han T, Mo X, et al
    Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0435.
    PubMed     Text format     Abstract available


  70. WIKTOR-JEDRZEJCZAK W, Drozd-Sokolowska J, Eikema DJ, Hoek J, et al
    EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL).
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0448.
    PubMed     Text format     Abstract available


  71. KE P, Bao X, Qiu H, Zhuang J, et al
    Central nervous system complications caused by 3-4 grade aGVHD in adult patients occurred in HLA-mismatched recipients majorly after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0443.
    PubMed     Text format    


  72. ABADIR E, Bryant C, Larsen S, Clark GJ, et al
    Targeting the niche: depleting haemopoietic stem cells with targeted therapy.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0445.
    PubMed     Text format     Abstract available


  73. ADKINS BD, Savani BN, Booth GS
    Transgender individuals represent an overlooked population amongst stem cell donors.
    Bone Marrow Transplant. 2019 Jan 18. pii: 10.1038/s41409-019-0437.
    PubMed     Text format    


  74. HINO T, Imi T, Hangaishi A, Kamoda Y, et al
    Escape hematopoiesis by donor-derived 6pLOH(+) hematopoietic stem cells in a marrow transplant recipient with late graft failure.
    Bone Marrow Transplant. 2019 Jan 10. pii: 10.1038/s41409-018-0420.
    PubMed     Text format    


    December 2018
  75. WANG RC, Mori S, Zhu X, Varela JC, et al
    Increased bone marrow CD56(bright) natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome.
    Bone Marrow Transplant. 2018 Dec 18. pii: 10.1038/s41409-018-0407.
    PubMed     Text format    


  76. USTUN C, Young JH, Papanicolaou GA, Kim S, et al
    Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2018 Dec 13. pii: 10.1038/s41409-018-0401.
    PubMed     Text format     Abstract available


  77. ALATRASH G, Kidwell KM, Thall PF, Di Stasi A, et al
    Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS.
    Bone Marrow Transplant. 2018 Dec 10. pii: 10.1038/s41409-018-0405.
    PubMed     Text format     Abstract available


  78. UMEDA K, Yabe H, Kato K, Imai K, et al
    Impact of low-dose irradiation and in vivo T-cell depletion on hematopoietic stem cell transplantation for non-malignant diseases using fludarabine-based reduced-intensity conditioning.
    Bone Marrow Transplant. 2018 Dec 7. pii: 10.1038/s41409-018-0418.
    PubMed     Text format     Abstract available


  79. INAMOTO Y, Valdes-Sanz N, Ogawa Y, Alves M, et al
    Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2018 Dec 7. pii: 10.1038/s41409-018-0340.
    PubMed     Text format     Abstract available


  80. BONDANZA A, Ruggeri L, Noviello M, Eikema DJ, et al
    Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting.
    Bone Marrow Transplant. 2018 Dec 7. pii: 10.1038/s41409-018-0351.
    PubMed     Text format     Abstract available


  81. ZHAO J, Zu Y, Han L, Zhang Y, et al
    Treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusion.
    Bone Marrow Transplant. 2018 Dec 5. pii: 10.1038/s41409-018-0409.
    PubMed     Text format     Abstract available


    November 2018
  82. HIGASHINO HR, Marchi AP, Martins RCR, Batista MV, et al
    Colistin-resistant Klebsiella pneumoniae co-harboring KPC and MCR-1 in a Hematopoietic Stem Cell Transplantation Unit.
    Bone Marrow Transplant. 2018 Nov 30. pii: 10.1038/s41409-018-0416.
    PubMed     Text format    


  83. BAIER DM, Hofmann JA, Fischer H, Rall G, et al
    Very low error rates of NGS-based HLA typing at stem cell donor recruitment question the need for a standard confirmatory typing step before donor work-up.
    Bone Marrow Transplant. 2018 Nov 30. pii: 10.1038/s41409-018-0411.
    PubMed     Text format    


  84. JELINEK T, Adamusova L, Popkova T, Tvrda I, et al
    Cytarabine + G-CSF is more effective than cyclophosphamide + G-CSF as a stem cell mobilization regimen in multiple myeloma.
    Bone Marrow Transplant. 2018 Nov 20. pii: 10.1038/s41409-018-0396.
    PubMed     Text format     Abstract available


  85. YANG J, Jiang J, Cai Y, Li S, et al
    Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malig
    Bone Marrow Transplant. 2018 Nov 16. pii: 10.1038/s41409-018-0382.
    PubMed     Text format     Abstract available


  86. GOWDA L, Shah M, Badar I, Bashir Q, et al
    Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs.
    Bone Marrow Transplant. 2018 Nov 16. pii: 10.1038/s41409-018-0392.
    PubMed     Text format     Abstract available


  87. KUMAR A, Reljic T, Hamadani M, Mohty M, et al
    Antithymocyte globulin for graft-versus-host disease prophylaxis: an updated systematic review and meta-analysis.
    Bone Marrow Transplant. 2018 Nov 16. pii: 10.1038/s41409-018-0393.
    PubMed     Text format     Abstract available


  88. WULF G, Hasenkamp J, Jung W, Wilhelm C, et al
    Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease.
    Bone Marrow Transplant. 2018 Nov 9. pii: 10.1038/s41409-018-0360.
    PubMed     Text format     Abstract available


  89. TROVILLION EM, Gloude NJ, Anderson EJ, Morris GP, et al
    Relationship of post-transplant thymopoiesis with CD4(+)FoxP3(+) regulatory T cell recovery associated with freedom from chronic graft versus host disease.
    Bone Marrow Transplant. 2018 Nov 9. pii: 10.1038/s41409-018-0394.
    PubMed     Text format    


  90. PAGLIARDINI T, Harbi S, Furst S, Castagna L, et al
    Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0387.
    PubMed     Text format     Abstract available


  91. GERULL S, Tschan-Plessl A, Mathew R, Nair G, et al
    Late relapse after stopping sorafenib in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0376.
    PubMed     Text format    


  92. ROS-SOTO J, Anthias C, Madrigal A, Snowden JA, et al
    Vitamin D: is it important in haematopoietic stem cell transplantation? A review.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0377.
    PubMed     Text format     Abstract available


  93. KNOLL BM, Seiter K, Phillips A, Soave R, et al
    Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0389.
    PubMed     Text format    


  94. WEBER D, Weber M, Hippe K, Ghimire S, et al
    Non-invasive diagnosis of acute intestinal graft-versus-host disease by a new scoring system using ultrasound morphology, compound elastography, and contrast-enhanced ultrasound.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0381.
    PubMed     Text format     Abstract available


  95. NORMAN JE, Schouten HC, Dreger P, Robinson SP, et al
    The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0372.
    PubMed     Text format     Abstract available


  96. GALLANAGH M, Shaw O, Kaur H, Raj K, et al
    Successful engraftment in recipients of haploidentical stem cells with donor-specific antibodies: role of flow cytometric cross-match.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0384.
    PubMed     Text format    


  97. GHILARDI G, Pabst T, Jeker B, Muller R, et al
    Melphalan dose in myeloma patients >/=65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0379.
    PubMed     Text format     Abstract available


  98. SIDIQI MH, Aljama MA, Muchtar E, Buadi FK, et al
    Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0388.
    PubMed     Text format     Abstract available


  99. GIEBEL S, Marks DI, Boissel N, Baron F, et al
    Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute L
    Bone Marrow Transplant. 2018 Nov 1. pii: 10.1038/s41409-018-0373.
    PubMed     Text format     Abstract available


  100. EICHENBERGER EM, Soave R, Zappetti D, Small CB, et al
    Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2018 Nov 1. pii: 10.1038/s41409-018-0386.
    PubMed     Text format     Abstract available


    October 2018
  101. PATEL SS, Rybicki LA, Corrigan D, Dumont C, et al
    Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2018 Oct 30. pii: 10.1038/s41409-018-0380.
    PubMed     Text format     Abstract available


  102. RIVERA D, Bastida JM, Lopez-Corral L, Sanchez-Guijo F, et al
    Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 24. pii: 10.1038/s41409-018-0368.
    PubMed     Text format    


  103. DANYLESKO I, Bukauskas A, Paulson M, Peceliunas V, et al
    Anti-alpha4beta7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Oct 24. pii: 10.1038/s41409-018-0364.
    PubMed     Text format     Abstract available


  104. KAROW A, Wilhelm A, Ammann RA, Baerlocher GM, et al
    Peripheral blood progenitor cell collection in pediatric patients optimized by high pre-apheresis count of circulating CD34+ cells and high blood flow.
    Bone Marrow Transplant. 2018 Oct 23. pii: 10.1038/s41409-018-0353.
    PubMed     Text format     Abstract available


  105. HARASHIMA S, Yoneda R, Horie T, Fujioka Y, et al
    Psychosocial Assessment of Candidates for Transplantation scale (PACT) and survival after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 23. pii: 10.1038/s41409-018-0371.
    PubMed     Text format     Abstract available


  106. JABBOUR J, Manana B, Sakr M, Zahreddine A, et al
    The impact of counseling on nutritional status among hematopoietic stem cell recipients: results of a randomized controlled trial.
    Bone Marrow Transplant. 2018 Oct 22. pii: 10.1038/s41409-018-0366.
    PubMed     Text format    


  107. ZIEGLER AK, Abend M, Port M, Dammann E, et al
    Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0359.
    PubMed     Text format    


  108. SHAH MV, Saliba RM, Rondon G, Chen J, et al
    Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0367.
    PubMed     Text format     Abstract available


  109. HAYAKAWA J, Miyamura D, Kimura SI, Gomyo A, et al
    Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0365.
    PubMed     Text format     Abstract available


  110. KALOYANNIDIS P, Shaibani EA, Apostolidis I, Kanfar S, et al
    Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0362.
    PubMed     Text format    


  111. DE LA HOZ A, Foolad F, Gallegos C, Kornblau S, et al
    Nivolumab-induced encephalitis post allogeneic stem cell transplant in a patient with Hodgkin's disease.
    Bone Marrow Transplant. 2018 Oct 15. pii: 10.1038/s41409-018-0363.
    PubMed     Text format    


  112. KUROSAWA S, Yamaguchi T, Oshima K, Yanagisawa A, et al
    Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0343.
    PubMed     Text format    


  113. BAE SK, Gushima T, Saito N, Yamanaka I, et al
    HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0355.
    PubMed     Text format    


  114. MOUKALLED NM, El Darsa H, Haibe Y, Massoud R, et al
    Feasibility of Venetoclax-based combinations for adult patients with acute myeloid leukemia relapsing after allogenic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0347.
    PubMed     Text format    


  115. PAHNKE S, Egeland T, Halter J, Hagglund H, et al
    Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation.
    Bone Marrow Transplant. 2018 Oct 3. pii: 10.1038/s41409-018-0350.
    PubMed     Text format     Abstract available


  116. DOS SANTOS KB, Costa LJM, Bettarello G, da Matta Abreu M, et al
    LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma.
    Bone Marrow Transplant. 2018 Oct 3. pii: 10.1038/s41409-018-0349.
    PubMed     Text format    


  117. PINGEL J, Wang T, Hagenlocher Y, Hernandez-Frederick CJ, et al
    The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation - a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR.
    Bone Marrow Transplant. 2018 Oct 2. pii: 10.1038/s41409-018-0345.
    PubMed     Text format     Abstract available


    September 2018
  118. SMELAND KB, Loge JH, Aass HCD, Aspelin T, et al
    Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity.
    Bone Marrow Transplant. 2018 Sep 27. pii: 10.1038/s41409-018-0342.
    PubMed     Text format    


  119. JAIME-PEREZ JC, Salazar-Cavazos L, Aguilar-Calderon P, Herrera-Garza JL, et al
    Assessing the efficacy of an ambulatory peripheral blood hematopoietic stem cell transplant program using reduced intensity conditioning in a low-middle-income country.
    Bone Marrow Transplant. 2018 Sep 21. pii: 10.1038/s41409-018-0338.
    PubMed     Text format     Abstract available


  120. SALEEM MS, Aljurf M, Srivastava A, Shamsi T, et al
    Challenges in managing graft-versus-host disease in developing countries: a perspective.
    Bone Marrow Transplant. 2018 Sep 20. pii: 10.1038/s41409-018-0333.
    PubMed     Text format     Abstract available


  121. BONIFAZI F, Dan E, Labopin M, Sessa M, et al
    Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study.
    Bone Marrow Transplant. 2018 Sep 19. pii: 10.1038/s41409-018-0335.
    PubMed     Text format     Abstract available


  122. NAFTULIN JS, Penzi LR, Manatis-Lornell A, Yasuda MR, et al
    Longstanding alopecia and nail dystrophy are associated with more severe overall chronic graft-versus-host disease in adults.
    Bone Marrow Transplant. 2018 Sep 13. pii: 10.1038/s41409-018-0309.
    PubMed     Text format    


    August 2018
  123. KAMEDA K, Kimura SI, Misaki Y, Yoshimura K, et al
    Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 31. pii: 10.1038/s41409-018-0330.
    PubMed     Text format     Abstract available


  124. TSANG ES, Villa D, Loscocco F, Visani G, et al
    High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 31. pii: 10.1038/s41409-018-0328.
    PubMed     Text format    


  125. LIN RJ, Elko TA, Perales MA, Alexander K, et al
    End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer center.
    Bone Marrow Transplant. 2018 Aug 22. pii: 10.1038/s41409-018-0311.
    PubMed     Text format     Abstract available


  126. MOHANAN E, Panetta JC, Lakshmi KM, Edison ES, et al
    Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 22. pii: 10.1038/s41409-018-0276.
    PubMed     Text format     Abstract available


  127. CHAULAGAIN CP, Sprague KA, Pilichowska M, Cowan J, et al
    Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
    Bone Marrow Transplant. 2018 Aug 20. pii: 10.1038/s41409-018-0299.
    PubMed     Text format     Abstract available


  128. YAKUSHIJIN K, Ikezoe T, Ohwada C, Kudo K, et al
    Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 20. pii: 10.1038/s41409-018-0304.
    PubMed     Text format     Abstract available


  129. KANELLOPOULOS A, Kaparou M, Xenou E, Paneesha S, et al
    Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0297.
    PubMed     Text format     Abstract available


  130. LADETTO M, Bottcher S, Kroger N, Pulsipher MA, et al
    Methods and role of minimal residual disease after stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0307.
    PubMed     Text format     Abstract available


  131. PICCALUGA PP, Rapezzi D, Gazzola A, Malagola M, et al
    Resolving the diagnostic dilemma of T-cell clonal expansion after hematopoietic stem cell transplantation in T-cell lymphoma patients by TCR-gamma next generation sequencing.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0268.
    PubMed     Text format    


  132. MILLER KC, Gertz MA, Buadi FK, Hayman SR, et al
    Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0302.
    PubMed     Text format     Abstract available


  133. GUNES G, Goker H, Demiroglu H, Malkan UY, et al
    Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0303.
    PubMed     Text format     Abstract available


  134. MATSUDA K, Honda A, Arai S, Maki H, et al
    Retrospective analysis on transient recurrence of steroid-sensitive acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0274.
    PubMed     Text format    


  135. DABAS R, Dharmani-Khan P, Modi M, Van Slyke T, et al
    Anti-thymocyte globulin's activity against acute myeloid leukemia stem cells.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0296.
    PubMed     Text format     Abstract available


  136. BITTENCOURT MCB, Mariano L, Moreira F, Schmidt-Filho J, et al
    Cryopreserved versus non-cryopreserved peripheral blood stem cells for autologous transplantation after high-dose Melphalan in multiple myeloma: comparative analysis.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0250.
    PubMed     Text format    


  137. KRAFT S, Bollinger N, Bodenmann B, Heim D, et al
    High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0293.
    PubMed     Text format     Abstract available


  138. PHILIPPE M, Neely M, Rushing T, Bertrand Y, et al
    Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0281.
    PubMed     Text format     Abstract available


  139. MARTELIN E, Volin L, Itala-Remes M, Niittyvuopio R, et al
    Incidence and risk factors of secondary cancers after allogeneic stem cell transplantation: analysis of a single centre cohort with a long follow-up.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0290.
    PubMed     Text format    


  140. DOUCETTE K, Tian X, Chawla U, Jain NA, et al
    Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0282.
    PubMed     Text format    


  141. PHILLIPS EH, Lannon MM, Lopes A, Chadwick H, et al
    High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0294.
    PubMed     Text format    


  142. VARGA C, Comenzo RL
    High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0284.
    PubMed     Text format     Abstract available


  143. KEREP AZ, Broome J, Pirsl F, Curtis LM, et al
    Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0224.
    PubMed     Text format     Abstract available


  144. PERIC Z, Skegro I, Durakovic N, Desnica L, et al
    Amniotic membrane transplantation-a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0140.
    PubMed     Text format    


  145. MUKHERJEE A, Ekinci E, Scholoff A, Obi G, et al
    Voriconazole photosensitivity causes apparent graft-versus-host disease exacerbation.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0285.
    PubMed     Text format    


  146. KONISHI Y, Kondo T, Nakao K, Asagoe K, et al
    Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0287.
    PubMed     Text format    


  147. SUGITA J, Kagaya Y, Miyamoto T, Shibasaki Y, et al
    Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0279.
    PubMed     Text format     Abstract available


  148. BALDOMERO H, Aljurf M, Zaidi SZA, Hashmi SK, et al
    Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends.
    Bone Marrow Transplant. 2018 Aug 6. pii: 10.1038/s41409-018-0275.
    PubMed     Text format     Abstract available


  149. VAN DER HEIDEN PLJ, Arbous MS, van Beers EJ, van den Bergh WM, et al
    Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 6. pii: 10.1038/s41409-018-0277.
    PubMed     Text format     Abstract available


    July 2018
  150. HIRANO M, Jimbo K, Ogawa M, Ochi K, et al
    Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0202.
    PubMed     Text format    


  151. SAITO A, Nishikawa T, Oyoshi T, Nakagawa S, et al
    Giant radiation-induced cavernous haemangioma before reduced-intensity bone marrow transplantation for acute lymphoblastic leukaemia.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0272.
    PubMed     Text format    


  152. CHEN YB, McCarthy PL, Hahn T, Holstein SA, et al
    Methods to prevent and treat relapse after hematopoietic stem cell transplantation with tyrosine kinase inhibitors, immunomodulating drugs, deacetylase inhibitors, and hypomethylating agents.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0269.
    PubMed     Text format     Abstract available


  153. BHUTANI D, Jaiyeoba C, Kim S, Naylor P, et al
    Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0270.
    PubMed     Text format    


  154. HAGEN PA, Adams W, Smith S, Tsai S, et al
    Low mean post-transplantation tacrolimus levels in weeks 2-3 correlate with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation from related and unrelated donors.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0267.
    PubMed     Text format    


  155. TAY J, Daly A, Jamani K, Labelle L, et al
    Patient eligibility for hematopoietic stem cell transplantation: a review of patient-associated variables.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0265.
    PubMed     Text format     Abstract available


  156. GONSALVES WI, Buadi FK, Ailawadhi S, Bergsagel PL, et al
    Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0264.
    PubMed     Text format     Abstract available


  157. YANG B, Yu R, Cai L, Bin Guo, et al
    Haploidentical versus matched donor stem cell transplantation for patients with hematological malignancies: a systemic review and meta-analysis.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0239.
    PubMed     Text format     Abstract available


    June 2018
  158. TOMIZAWA D, Yoshida M, Kondo T, Miyamura T, et al
    Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.
    Bone Marrow Transplant. 2018 Jun 29. pii: 10.1038/s41409-018-0273.
    PubMed     Text format     Abstract available


  159. TANG S, Shen H, Qu C, Dai H, et al
    Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.
    Bone Marrow Transplant. 2018 Jun 25. pii: 10.1038/s41409-018-0249.
    PubMed     Text format     Abstract available


  160. CHUNG H, Hong KT, Lee JW, Rhee SJ, et al
    Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients.
    Bone Marrow Transplant. 2018 Jun 18. pii: 10.1038/s41409-018-0260.
    PubMed     Text format     Abstract available


  161. HARI P, Reece DE, Randhawa J, Flomenberg N, et al
    Final outcomes of escalated melphalan 280 mg/m(2) with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival.
    Bone Marrow Transplant. 2018 Jun 15. pii: 10.1038/s41409-018-0261.
    PubMed     Text format     Abstract available


  162. NYGAARD M, Karlsmark T, Andersen NS, Schjodt IM, et al
    Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease-experience with three different approaches.
    Bone Marrow Transplant. 2018 Jun 15. pii: 10.1038/s41409-018-0262.
    PubMed     Text format    


  163. MALARD F, Gasc C, Plantamura E, Dore J, et al
    High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients.
    Bone Marrow Transplant. 2018 Jun 14. pii: 10.1038/s41409-018-0254.
    PubMed     Text format    


  164. WONG E, Davis JE, Grigg A, Szer J, et al
    Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 14. pii: 10.1038/s41409-018-0244.
    PubMed     Text format     Abstract available


  165. SOLANO C, Gimenez E, Albert E, Mateo EM, et al
    Pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0251.
    PubMed     Text format     Abstract available


  166. GABELLI M, Zecca M, Messina C, Carraro E, et al
    Hematopoietic stem cell transplantation for isolated extramedullary relapse of acute lymphoblastic leukemia in children.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0259.
    PubMed     Text format     Abstract available


  167. HOCHBERG J, Zahler S, Geyer MB, Chen N, et al
    The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leuke
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0247.
    PubMed     Text format     Abstract available


  168. NADEMI Z, Wynn RF, Slatter M, Hughes SM, et al
    Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0246.
    PubMed     Text format    


  169. MOOR I, Bacher VU, Jeker B, Taleghani BM, et al
    Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0245.
    PubMed     Text format    


  170. DOESCHER A, Casper J, Kraemer D, Kapels HH, et al
    Digital PCR to assess platelet recovery after stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0238.
    PubMed     Text format    


  171. WHITE PS, Phull P, Brauneis D, Sloan JM, et al
    High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0242.
    PubMed     Text format    


  172. AL-SAUD B, Al-Jomaie M, Al-Ghonaium A, Al-Ahmari A, et al
    Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0219.
    PubMed     Text format     Abstract available


  173. GRIFFIN SP, Wheeler SE, Wiggins LE, Murthy HS, et al
    Pharmacokinetic and clinical outcomes when ideal body weight is used to dose busulfan in obese hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0240.
    PubMed     Text format     Abstract available


  174. ROBINSON SP, Boumendil A, Finel H, Dreger P, et al
    High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working Party.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0196.
    PubMed     Text format     Abstract available


  175. SORENSEN CD, Moller BK, Olesen G, Hokland P, et al
    Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0229.
    PubMed     Text format    


  176. SCHOEMANS HM, Lee SJ, Ferrara JL, Wolff D, et al
    EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.
    Bone Marrow Transplant. 2018 Jun 5. pii: 10.1038/s41409-018-0204.
    PubMed     Text format    


    May 2018
  177. BURT RK, Han X, Gozdziak P, Yaung K, et al
    Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome.
    Bone Marrow Transplant. 2018 May 31. pii: 10.1038/s41409-018-0173.
    PubMed     Text format     Abstract available


  178. MA CKK, Garcia-Cadenas I, Fox ML, Ai S, et al
    Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0215.
    PubMed     Text format    


  179. SUREDA A, Dreger P, Bishop MR, Kroger N, et al
    Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0214.
    PubMed     Text format     Abstract available


  180. JAIN T, Kunze KL, Temkit M, Partain DK, et al
    Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0226.
    PubMed     Text format     Abstract available


  181. GANETSKY A, Frey NV, Hexner EO, Loren AW, et al
    Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0236.
    PubMed     Text format     Abstract available


  182. KATO M, Kurata M, Kanda J, Kato K, et al
    Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0221.
    PubMed     Text format     Abstract available


  183. GOKBUGET N, Canaani J, Nagler A, Bishop M, et al
    Prevention and treatment of relapse after stem cell transplantation with immunotherapy.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0232.
    PubMed     Text format     Abstract available


  184. FALKENBURG F, Ruggiero E, Bonini C, Porter D, et al
    Prevention and treatment of relapse after stem cell transplantation by cellular therapies.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0227.
    PubMed     Text format     Abstract available


  185. PHAN TL, Pritchett JC, Leifer C, Zerr DM, et al
    HHV-6B infection, T-cell reconstitution, and graft-vs-host disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0225.
    PubMed     Text format     Abstract available


  186. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
    Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0223.
    PubMed     Text format    


  187. MANJAPPA S, Fiala MA, King J, Kohnen DA, et al
    The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0216.
    PubMed     Text format    


  188. JACOBSE J, Mensink H, van der Stoep-Yap MYEC, Kollen WJW, et al
    Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0231.
    PubMed     Text format    


  189. DAMLAJ M, Alaskar A, Ghazi S, Alahmari B, et al
    Peripheral hematopoietic stem cell mobilization utilizing growth factors in donors with sickle cell trait is safe and effective.
    Bone Marrow Transplant. 2018 May 9. pii: 10.1038/s41409-018-0208.
    PubMed     Text format    


  190. TKACZYK ER, Chen F, Wang J, Gandelman JS, et al
    Overcoming human disagreement assessing erythematous lesion severity on 3D photos of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0211.
    PubMed     Text format    


  191. SATO T, Seto A, Kagaya Y, Kawashima N, et al
    Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0197.
    PubMed     Text format    


  192. NYGAARD M, Karlsmark T, Andersen NS, Schjodt IM, et al
    Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0206.
    PubMed     Text format     Abstract available


  193. TAGEJA N, Korde N, Kazandjian D, Panch S, et al
    Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0170.
    PubMed     Text format     Abstract available


  194. KONUMA T, Kohara C, Watanabe E, Mizukami M, et al
    Circulating monocyte subsets in human chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0187.
    PubMed     Text format     Abstract available


  195. SAAD A, Taneja A, Di Stasi A, Sarmad R, et al
    Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0185.
    PubMed     Text format    


  196. ASLAM HM, Yousuf S, Kassim A, Iqbal SM, et al
    Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0193.
    PubMed     Text format     Abstract available


  197. CHEN Y, Xu LP, Zhang XH, Chen H, et al
    Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis.
    Bone Marrow Transplant. 2018 May 3. pii: 10.1038/s41409-018-0175.
    PubMed     Text format    


  198. SELLMANN L, Rabe K, Bunting I, Dammann E, et al
    Diagnostic value of highly-sensitive chimerism analysis after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 2. pii: 10.1038/s41409-018-0176.
    PubMed     Text format     Abstract available


    April 2018
  199. YANG L, Tan Y, Shi J, Zhao Y, et al
    Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.
    Bone Marrow Transplant. 2018 Apr 30. pii: 10.1038/s41409-018-0184.
    PubMed     Text format    


  200. GUTIERREZ-GARCIA G, Rovira M, Magnano L, Rosinol L, et al
    Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 29. pii: 10.1038/s41409-018-0189.
    PubMed     Text format     Abstract available


  201. PRESTES DP, Mendes C, Batista MV, Ramos JF, et al
    A case-series of Toxoplasmosis in hematopoietic stem cell transplantation: still a concern for endemic countries.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0179.
    PubMed     Text format    


  202. AERTS-KAYA F, Koca G, Sharafi P, Sayla FC, et al
    Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+ cell numbers.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0192.
    PubMed     Text format    


  203. NOGUCHI M, Moritake H, Kamimura S, Sonoda M, et al
    Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet's disease and secondary myelodysplastic syndrome.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0180.
    PubMed     Text format    


  204. SOLANO C, Talaya A, Gimenez E, Albert E, et al
    Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?
    Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0191.
    PubMed     Text format    


  205. BROWNBACK KR, Pitts LR, Abhyankar S
    Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0182.
    PubMed     Text format    


  206. JODELE S, Dandoy CE, Myers K, Wallace G, et al
    High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma.
    Bone Marrow Transplant. 2018 Apr 19. pii: 10.1038/s41409-018-0159.
    PubMed     Text format     Abstract available


  207. HOROWITZ M, Schreiber H, Elder A, Heidenreich O, et al
    Epidemiology and biology of relapse after stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 18. pii: 10.1038/s41409-018-0171.
    PubMed     Text format    


  208. PEREZ L, Fernandez H, Horna P, Riches M, et al
    Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Apr 18. pii: 10.1038/s41409-018-0163.
    PubMed     Text format     Abstract available


  209. GRECO R, Ciceri F, Noviello M, Bondanza A, et al
    Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP.
    Bone Marrow Transplant. 2018 Apr 17. pii: 10.1038/s41409-018-0167.
    PubMed     Text format    


  210. PERIC Z, Wilson J, Durakovic N, Ostojic A, et al
    Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 16. pii: 10.1038/s41409-018-0172.
    PubMed     Text format     Abstract available


  211. BATTIPAGLIA G, Ruggeri A, Labopin M, Volin L, et al
    Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia.
    Bone Marrow Transplant. 2018 Apr 16. pii: 10.1038/s41409-018-0169.
    PubMed     Text format     Abstract available


    March 2018
  212. NAITHANI R, Dayal N, Pathak S, Rai R, et al
    Hematopoietic stem cell transplantation using non-cryopreserved peripheral blood stem cells graft is effective in multiple myeloma and lymphoma.
    Bone Marrow Transplant. 2018 Mar 29. pii: 10.1038/s41409-018-0174.
    PubMed     Text format    


  213. CASTAGNOLA E, Bagnasco F, Menoni S, Muraca M, et al
    Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GIT
    Bone Marrow Transplant. 2018 Mar 21. pii: 10.1038/s41409-018-0160.
    PubMed     Text format    


  214. YAHNG SA, Park SS, Jeon YW, Yoon JH, et al
    Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia.
    Bone Marrow Transplant. 2018 Mar 21. pii: 10.1038/s41409-018-0154.
    PubMed     Text format     Abstract available


  215. GAAFAR A, Sheereen A, Almohareb F, Eldali A, et al
    Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.
    Bone Marrow Transplant. 2018 Mar 16. pii: 10.1038/s41409-018-0123.
    PubMed     Text format     Abstract available


  216. VAN DER WAGEN L, Te Boome L, Schiffler M, Nijhof I, et al
    Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib.
    Bone Marrow Transplant. 2018 Mar 16. pii: 10.1038/s41409-018-0158.
    PubMed     Text format     Abstract available


  217. GASSAS A, Sivaprakasam P, Cummins M, Breslin P, et al
    High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0157.
    PubMed     Text format     Abstract available


  218. BENEVENTI F, Locatelli E, Simonetta M, Cavagnoli C, et al
    Vaginal development and sexual functioning in young women after stem cell transplantation, chemotherapy, and/or radiotherapy for childhood hematological diseases.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0149.
    PubMed     Text format     Abstract available


  219. SCHMIDT V, Niederwieser D, Schenk T, Behre G, et al
    Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0135.
    PubMed     Text format    


  220. KORDELAS L, da Silva Nardi F, Wagner B, Ditschkowski M, et al
    Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Mar 14. pii: 10.1038/s41409-018-0145.
    PubMed     Text format     Abstract available


  221. RICHARDS S, Choo S, Mechinaud F, Cole T, et al
    Single centre results of targeted busulphan, fludarabine and serotherapy conditioning in haematopoietic stem cell transplantation for haemophagocytic lymphohistiocytosis.
    Bone Marrow Transplant. 2018 Mar 13. pii: 10.1038/s41409-018-0125.
    PubMed     Text format    


  222. CHUA CC, Lim HY, Chai KL, Ong J, et al
    Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0152.
    PubMed     Text format     Abstract available


  223. TROEGER H, Hering NA, Bojarski C, Fromm A, et al
    Epithelial barrier dysfunction as permissive pathomechanism in human intestinal graft-versus-host disease.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0144.
    PubMed     Text format    


  224. DEBALS-GONTHIER M, Siani C, Faucher C, Touzani R, et al
    Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0133.
    PubMed     Text format     Abstract available


  225. LAMB LS, Pillai S, Langford S, Bowersock J, et al
    Clinical-scale manufacturing of gammadelta T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0130.
    PubMed     Text format    


  226. PERIC Z, Botti S, Stringer J, Krawczyk J, et al
    Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0137.
    PubMed     Text format     Abstract available


  227. CHENG Z, Zhou L, Hu K, Dai Y, et al
    Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0146.
    PubMed     Text format     Abstract available


    February 2018
  228. GJAERDE LK, Schmidt M, Sengelov H
    Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Feb 28. pii: 10.1038/s41409-018-0131.
    PubMed     Text format    


  229. AVIVI I, Boumendil A, Finel H, Nagler A, et al
    Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2018 Feb 20. pii: 10.1038/s41409-017-0063.
    PubMed     Text format     Abstract available


  230. BUBALO J, Mulverhill K, Meyers G, Hayes-Lattin B, et al
    A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoie
    Bone Marrow Transplant. 2018 Feb 20. pii: 10.1038/s41409-018-0106.
    PubMed     Text format     Abstract available


  231. SARMIENTO M, Ramirez P, Parody R, Salas MQ, et al
    Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy.
    Bone Marrow Transplant. 2018 Feb 13. pii: 10.1038/s41409-018-0117.
    PubMed     Text format     Abstract available


  232. MARCHESI F, Capria S, Giannarelli D, Trisolini SM, et al
    BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant.
    Bone Marrow Transplant. 2018 Feb 13. pii: 10.1038/s41409-018-0120.
    PubMed     Text format    


  233. WATTS MJ, Ings SJ, Dorman J, Rabin N, et al
    Use of split peripheral blood stem cell harvests in myeloma identifies functional preservation of progenitor cells cryopreserved for several years and demonstrates no functional damage to the bone marrow microenvironment.
    Bone Marrow Transplant. 2018 Feb 12. pii: 10.1038/s41409-018-0121.
    PubMed     Text format    


  234. HSU YT, Tsai HJ, Chang JS, Li SS, et al
    Stem cell transplantation for T-cell lymphomas in Taiwan.
    Bone Marrow Transplant. 2018 Feb 12. pii: 10.1038/s41409-018-0116.
    PubMed     Text format     Abstract available


  235. BORCHERT-MORLINS B, Memaran N, Sauer M, Maecker-Kolhoff B, et al
    Cardiovascular risk factors and subclinical organ damage after hematopoietic stem cell transplantation in pediatric age.
    Bone Marrow Transplant. 2018 Feb 9. pii: 10.1038/s41409-018-0104.
    PubMed     Text format     Abstract available


  236. MASHEGU H, Smith L, Li Y, Seif A, et al
    The role of peritoneal drainage in veno-occlusive disease in pediatric patients post hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2018 Feb 6. pii: 10.1038/s41409-018-0113.
    PubMed     Text format    


  237. TETU P, Jachiet M, de Masson A, Hurabielle C, et al
    Chronic graft versus host disease presenting as lichen planus pigmentosus.
    Bone Marrow Transplant. 2018 Feb 6. pii: 10.1038/s41409-018-0110.
    PubMed     Text format    


  238. OZDOGU H, Boga C, Yeral M, Kozanoglu I, et al
    Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial.
    Bone Marrow Transplant. 2018 Feb 5. pii: 10.1038/s41409-018-0111.
    PubMed     Text format     Abstract available


  239. YOO KH, Kang D, Kim IR, Choi EK, et al
    Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study.
    Bone Marrow Transplant. 2018 Feb 5. pii: 10.1038/s41409-018-0097.
    PubMed     Text format     Abstract available


  240. ZHANG Q, Zhou Y, Majaw JK, Xu J, et al
    Acute appendicitis in leukaemia patients undergoing haematopoietic stem cell transplantation during the neutropaenic phase: a case series from a single BMT centre in China.
    Bone Marrow Transplant. 2018;53:219-222.
    PubMed     Text format    


  241. NYGAARD M, Andersen NS, Moser CE, Olesen G, et al
    Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival.
    Bone Marrow Transplant. 2018 Feb 1. pii: 10.1038/s41409-018-0099.
    PubMed     Text format     Abstract available


    January 2018
  242. PATHAK M, Diep PP, Lai X, Brinch L, et al
    Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation.
    Bone Marrow Transplant. 2018 Jan 30. pii: 10.1038/s41409-018-0090.
    PubMed     Text format     Abstract available


  243. TURCOTTE LM, Wang T, Hemmer MT, Spellman SR, et al
    Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.
    Bone Marrow Transplant. 2018 Jan 30. pii: 10.1038/s41409-018-0100.
    PubMed     Text format    


  244. BADER P, Kuci Z, Bakhtiar S, Basu O, et al
    Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-018-0102.
    PubMed     Text format     Abstract available


  245. APITHY MJ, Charbonnier A, Desoutter J, Diouf M, et al
    Impact of MICA and NKG2D polymorphisms in HLA-fully matched related and unrelated hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-017-0083.
    PubMed     Text format    


  246. CALBI V, Fumagalli F, Consiglieri G, Penati R, et al
    Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy.
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-017-0085.
    PubMed     Text format    


  247. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
    Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-017-0082.
    PubMed     Text format    


  248. COLTOFF A, Lancman G, Kim S, Steinberg A, et al
    Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0094.
    PubMed     Text format    


  249. ALHASHIM N, Aljurf M, Hassanein M, Chaudhri N, et al
    Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0093.
    PubMed     Text format     Abstract available


  250. MOHAMMED J, Akomolafe T, Aljurf M, Savani B, et al
    'To treat or not to treat': raising awareness on the effects of graft versus host disease drugs on musculoskeletal system.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0095.
    PubMed     Text format    


  251. WOLFF D, Greinix H, Lee SJ, Gooley T, et al
    Biomarkers in chronic graft-versus-host disease: quo vadis?
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-018-0092.
    PubMed     Text format     Abstract available


  252. VAN DEN BRINK M, Uhrberg M, Jahn L, DiPersio JF, et al
    Selected biological issues affecting relapse after stem cell transplantation: role of T-cell impairment, NK cells and intrinsic tumor resistance.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0078.
    PubMed     Text format     Abstract available


  253. KOTCHETKOV R, Dyszkiewicz-Korpanty A, Kukreti V
    Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0080.
    PubMed     Text format    


  254. SAITO H, Ito M, Kato S, Kodera Y, et al
    The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0084.
    PubMed     Text format     Abstract available


  255. MERKER M, Meister MT, Rettinger E, Jarisch A, et al
    Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-018-0088.
    PubMed     Text format    


  256. KHOURY HJ, Langston AA, Kota VK, Wilkinson JA, et al
    Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0081.
    PubMed     Text format     Abstract available


  257. JIMENEZ-UBIETO A, Grande C, Caballero D, Yanez L, et al
    Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry.
    Bone Marrow Transplant. 2018 Jan 23. pii: 10.1038/s41409-018-0096.
    PubMed     Text format    


  258. ROBERT S, Albring JC, Frebel K, Opitz C, et al
    Alloantigen expression on malignant cells and healthy host tissue influences graft-versus-tumor reactions after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 23. pii: 10.1038/s41409-017-0071.
    PubMed     Text format     Abstract available


  259. LAHOUD OB, Moskowitz AJ, Horwitz SM, Giralt SA, et al
    Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma.
    Bone Marrow Transplant. 2018 Jan 22. pii: 10.1038/s41409-017-0086.
    PubMed     Text format    


  260. DIEP PP, Melberg HO, Brinch L, Buechner J, et al
    Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway.
    Bone Marrow Transplant. 2018 Jan 22. pii: 10.1038/s41409-018-0091.
    PubMed     Text format    


  261. MOHAMMED J, AlGhamdi A, Hashmi SK
    Full-body physical therapy evaluation for pre- and post-hematopoietic cell transplant patients and the need for a modified rehabilitation musculoskeletal specific grading system for chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 18. pii: 10.1038/s41409-017-0075.
    PubMed     Text format    


  262. FRANGOUL H, Evans M, Isbell J, Bruce K, et al
    Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide.
    Bone Marrow Transplant. 2018 Jan 16. pii: 10.1038/s41409-017-0077.
    PubMed     Text format    


  263. BAYDOUN M, Barton DL
    Complementary therapies for fatigue after hematopoietic stem cell transplantation: an integrative review.
    Bone Marrow Transplant. 2018 Jan 16. pii: 10.1038/s41409-017-0073.
    PubMed     Text format     Abstract available


  264. ROBINSON SP, Boumendil A, Finel H, Peggs KS, et al
    Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0067.
    PubMed     Text format     Abstract available


  265. HUO MR, Pei XY, Li D, Chang YJ, et al
    Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0072.
    PubMed     Text format     Abstract available


  266. CALORE E, Marzollo A, Cananzi M, Pizzi M, et al
    Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0065.
    PubMed     Text format    


  267. SCHUMACHER H, Stuwe S, Kropp P, Diedrich D, et al
    A prospective, randomized evaluation of the feasibility of exergaming on patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0070.
    PubMed     Text format     Abstract available


  268. REDDIVALLA N, Robinson AL, Reid KJ, Radhi MA, et al
    Using liver elastography to diagnose sinusoidal obstruction syndrome in pediatric patients undergoing hematopoetic stem cell transplant.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0064.
    PubMed     Text format     Abstract available


  269. SHICHIJO T, Fuji S, Tajima K, Kubo H, et al
    Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0045.
    PubMed     Text format    


  270. WALLACE G, Myers KC, Teusink-Cross A, Davies SM, et al
    Topical vitamin D analog for chronic graft versus host disease of the skin.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0031.
    PubMed     Text format    


  271. SCHMALBROCK LK, Bonifacio L, Bill M, Jentzsch M, et al
    Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0060.
    PubMed     Text format    


  272. GAUTHIER J, Poire X, Gac AC, Leclerc M, et al
    Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0018.
    PubMed     Text format     Abstract available


  273. KATZ MC, Michaelis S, Siegmund DM, Koch R, et al
    Association analysis between SUFU polymorphism rs17114808 and acute graft versus host disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0059.
    PubMed     Text format    


  274. FERREIRA AM, Pontes da Silva CA, Pereira AD, Szor RS, et al
    Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0068.
    PubMed     Text format    


  275. HAYASHI H, Ruggeri A, Volt F, Cornelissen JJ, et al
    Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0061.
    PubMed     Text format    


  276. JONES L, Dandoy C, Jodele S, Myers KC, et al
    Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0041.
    PubMed     Text format    


  277. LIU Y, Xu L, Zhang X, Wang Y, et al
    Acute kidney injury following haplo stem cell transplantation: incidence, risk factors and outcome.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0030.
    PubMed     Text format    


  278. CHEN Y, Lu J, Xu LP, Chen H, et al
    Safety and efficacy of haploidentical stem cell transplantation for multiple myeloma.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0069.
    PubMed     Text format    


  279. OLIVIERI J, Attolico I, Nuccorini R, Pascale SP, et al
    Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0051.
    PubMed     Text format     Abstract available


  280. OGAWA H, Ikegame K, Daimon T, Uchida N, et al
    Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0028.
    PubMed     Text format    


  281. FERNANDES JF, Bonfim C, Kerbauy FR, Rodrigues M, et al
    Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0015.
    PubMed     Text format     Abstract available


  282. DEVILLIER R, Labopin M, Chevallier P, Ledoux MP, et al
    Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Ma
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0043.
    PubMed     Text format     Abstract available


  283. SCHOEMANS HM, Goris K, Van Durm R, Vanbrabant K, et al
    Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0017.
    PubMed     Text format    


  284. MAYER K, Schumacher M, Eis-Hubinger AM, Pietzonka S, et al
    Intravesical cidofovir application in BK virus cystitis after allogeneic hematopoetic stem cell transplantation (HSCT) is safe and highly effective.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0044.
    PubMed     Text format    


    December 2017
  285. JUDET A, Copie-Bergman C, Zemoura L, Catherinot E, et al
    Epithelial chimerism in lung tissue after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0050.
    PubMed     Text format    


  286. FALCONE U, Jiang H, Bashir S, Tsang R, et al
    Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0054.
    PubMed     Text format    


  287. DEOTARE U, Atenafu EG, Loach D, Michelis FV, et al
    Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0053.
    PubMed     Text format    


  288. MITRUS I, Smagur A, Fidyk W, Czech M, et al
    Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0056.
    PubMed     Text format     Abstract available


  289. SEE WQ, Tung JY, Cheuk DK, Hwang YY, et al
    Endocrine complications in patients with transfusion-dependent thalassaemia after haemopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0052.
    PubMed     Text format    


  290. KUSKONMAZ B, Ayvaz D, Tezcan I, Yuce A, et al
    Successful hematopoietic stem cell transplantation after myeloablative conditioning in three patients with dedicator of cytokinesis 8 deficiency (DOCK8) related Hyper IgE syndrome.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0040.
    PubMed     Text format    


  291. DIROU S, Chambellan A, Chevallier P, Germaud P, et al
    Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0057.
    PubMed     Text format     Abstract available


  292. LOPEZ-INIGUEZ A, Carrera-Villanueva KA, Leon-Rodriguez E, Cuellar-Rodriguez J, et al
    Recurrent arthritis and immune reconstitution inflammatory syndrome in hematopoietic stem cell transplantation (HSCT).
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0058.
    PubMed     Text format    


  293. RAGON BK, Mehta RS, Gulbis AM, Saliba RM, et al
    Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0034.
    PubMed     Text format     Abstract available


  294. SWEISS K, Anderson J, Wirth S, Oh A, et al
    A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0024.
    PubMed     Text format     Abstract available


  295. SIDANA S, Tandon N, Gertz MA, Dispenzieri A, et al
    Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0020.
    PubMed     Text format     Abstract available


  296. NGUYEN VP, Brauneis D, Kaku M, Sloan JM, et al
    Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0048.
    PubMed     Text format    


  297. VAN GORKOM G, van Gelder M, Eikema DJ, Blok HJ, et al
    Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.
    Bone Marrow Transplant. 2017 Dec 18. pii: 10.1038/s41409-017-0023.
    PubMed     Text format     Abstract available


  298. UHM J, Shin E, Michelis FV, Thyagu S, et al
    Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment.
    Bone Marrow Transplant. 2017 Dec 15. pii: 10.1038/s41409-017-0025.
    PubMed     Text format    


    November 2017
  299. LEHRER J, Brissot E, Ruggeri A, Dulery R, et al
    Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study.
    Bone Marrow Transplant. 2017 Nov 20. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  300. FAROWSKI F, Bucker V, Vehreschild JJ, Biehl L, et al
    Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  301. CROCCHIOLO R, Ringden O, Bay JO, Blaise D, et al
    Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  302. CHAKRABORTY R, Muchtar E, Kumar SK, Buadi FK, et al
    Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  303. DOWLING MR, Li S, Dey BR, McAfee SL, et al
    Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    October 2017
  304. ALBERT E, Solano C, Gimenez E, Focosi D, et al
    The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  305. SIVARAJ D, Bacon W, Long GD, Rizzieri DA, et al
    High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  306. SHIN DY, Lee JH, Park S, Lee JO, et al
    Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  307. JEKER B, Novak U, Mansouri Taleghani B, Baerlocher GM, et al
    NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma.
    Bone Marrow Transplant. 2017 Oct 23. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  308. O'DWYER DN, Duvall AS, Xia M, Hoffman TC, et al
    Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 23. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  309. SHANIS D, Anandi P, Grant C, Bachi A, et al
    Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  310. MICHNIACKI TF, Mulcahy Levy JM, Quinones RR, Giller RH, et al
    Successful correction of familial hemophagocytic lymphohistiocytosis using prenatal genetic testing and preemptive hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  311. JOFFE E, Rosenberg D, Rozovski U, Perry C, et al
    Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  312. KANSAGRA A, Inwards DJ, Ansell SM, Micallef IN, et al
    Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  313. GOLDSMITH SR, Slade M, DiPersio JF, Westervelt P, et al
    Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  314. FOUZIA NA, Edison ES, Lakshmi KM, Korula A, et al
    Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  315. HEMMATI PG, Pfeifer K, Vuong LG, Jehn CF, et al
    Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  316. YOSHIMURA K, Yano I, Yamamoto T, Kawanishi M, et al
    Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  317. GERULL S, Denhaerynck K, Chalandon Y, Halter JP, et al
    Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  318. CHO C, Hsu M, Barba P, Maloy MA, et al
    Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  319. RE A, Gini G, Rupolo M, Levis A, et al
    Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  320. KROGER N, Bishop M, Giralt S, Wayne A, et al
    Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  321. KHOSLA J, Yeh AC, Spitzer TR, Dey BR, et al
    Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  322. GALIENI P, Troiani E, Bigazzi C, Mazzotta S, et al
    Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  323. LIU C, Frank DN, Horch M, Chau S, et al
    Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    September 2017
  324. MONTEFUSCO V, Mussetti A, Rezzonico F, Maura F, et al
    Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  325. ALMICI C, Skert C, Bruno B, Bianchetti A, et al
    Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  326. SCHEID C, de Wreede L, van Biezen A, Koenecke C, et al
    Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  327. KUBA K, Esser P, Mehnert A, Johansen C, et al
    Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    May 2017
  328. MALLHI K, Orchard PJ, Miller WP, Cao Q, et al
    Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature.
    Bone Marrow Transplant. 2017;52:726-732.
    PubMed     Text format     Abstract available


    January 2017
  329. HAVERKOS BM, Huang Y, Elder P, O'Donnell L, et al
    A single center's experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    February 2016
  330. MASOURIDI-LEVRAT S, Simonetta F, Beauverd Y, Tsopra O, et al
    Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants.
    Bone Marrow Transplant. 2016 Feb 8. doi: 10.1038/bmt.2015.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: